Astellas Joins International Agency for the Prevention of Blindness to Advocate for Better Eye Health Globally

IAPB is proud to announce that Astellas, a leading global pharmaceutical company, has joined as a Band A Member. This partnership strengthens the collective efforts of the eye health community to tackle the global burden of avoidable sight loss. 

Astellas brings its expertise in developing innovative treatments and its commitment to patient-centred care to this collaboration. Together, Astellas and IAPB will focus on: 

• Advocacy: Raising awareness of the importance of eye health and advocating for policies that promote access to quality eye care for all. 
• Research: Supporting research into the causes and prevention of blindness and vision impairment. 
• Capacity Building: Strengthening eye health systems and building the capacity of eye care professionals worldwide. 
• Collaboration: Working with other organisations and stakeholders to achieve greater impact in the fight against avoidable blindness. 

“Astellas is honoured to join the IAPB and contribute to the global effort to improve eye health,” said Anthony Yanni, Head of Patient Centricity at Astellas. “We believe that everyone deserves the access to eye care and are committed to working with IAPB and its members to make this a reality for people around the world.” 

“We are delighted to welcome Astellas to our membership,” said Peter Holland, Chief Executive of IAPB. “Their expertise and knowledge in the field of ophthalmology, coupled with their reach and commitment to patient care, will be invaluable assets in our shared mission to eliminate sight loss by 2030.” 

With over 2 billion people worldwide affected by preventable or treatable sight loss, the need for collaborative action is urgent. This partnership between Astellas and IAPB represents a significant step forward in the fight for better eye health for all.